BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26365441)

  • 1. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment.
    Ghilli M; Carretta E; Di Filippo F; Battaglia C; Fustaino L; Galanou I; Di Filippo S; Rucci P; Fantini MP; Roncella M
    Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26365441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Apr; 23(2):175-9. PubMed ID: 24484967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial.
    Houpeau JL; Chauvet MP; Guillemin F; Bendavid-Athias C; Charitansky H; Kramar A; Giard S
    J Surg Oncol; 2016 Apr; 113(5):501-7. PubMed ID: 26754343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
    Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Turkish SentiMAG feasibility trial: preliminary results.
    Vural V; Yılmaz OC
    Breast Cancer; 2020 Mar; 27(2):261-265. PubMed ID: 31621053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
    Karakatsanis A; Christiansen PM; Fischer L; Hedin C; Pistioli L; Sund M; Rasmussen NR; Jørnsgård H; Tegnelius D; Eriksson S; Daskalakis K; Wärnberg F; Markopoulos CJ; Bergkvist L
    Breast Cancer Res Treat; 2016 Jun; 157(2):281-294. PubMed ID: 27117158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.
    Karakatsanis A; Daskalakis K; Stålberg P; Olofsson H; Andersson Y; Eriksson S; Bergkvist L; Wärnberg F
    Br J Surg; 2017 Nov; 104(12):1675-1685. PubMed ID: 28877348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
    Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
    Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study.
    Piñero-Madrona A; Torró-Richart JA; de León-Carrillo JM; de Castro-Parga G; Navarro-Cecilia J; Domínguez-Cunchillos F; Román-Santamaría JM; Fuster-Diana C; Pardo-García R;
    Eur J Surg Oncol; 2015 Aug; 41(8):991-7. PubMed ID: 25997792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Magnetic Technique for Axillary Staging after Neoadjuvant Therapy in Breast Cancer Patients.
    Yılmaz OC; Vural V
    J Invest Surg; 2022 Jun; 35(6):1275-1278. PubMed ID: 35176950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SentiMag--the magnetic detection system of sentinel lymph nodes in breast cancer].
    Coufal O; Fait V; Lžičařová E; Chrenko V; Žaloudík J
    Rozhl Chir; 2015 Jul; 94(7):283-8. PubMed ID: 26305347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.
    Teshome M; Wei C; Hunt KK; Thompson A; Rodriguez K; Mittendorf EA
    Ann Surg Oncol; 2016 May; 23(5):1508-14. PubMed ID: 26893221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe.
    Taruno K; Kurita T; Kuwahata A; Yanagihara K; Enokido K; Katayose Y; Nakamura S; Takei H; Sekino M; Kusakabe M
    J Surg Oncol; 2019 Dec; 120(8):1391-1396. PubMed ID: 31667855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to the article by Thill et al.: "The Central-European SentiMag study: sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014.
    Barranger E; Ihrai T
    Breast; 2014 Jun; 23(3):297. PubMed ID: 24721742
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Krischer B; Forte S; Niemann T; Kubik-Huch RA; Leo C
    Eur J Surg Oncol; 2018 Jan; 44(1):74-79. PubMed ID: 29217399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Barranger E, Ihrai T, response to the article by Thill et al.: "The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014, 23(2):175-9.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Oct; 23(5):692. PubMed ID: 25067809
    [No Abstract]   [Full Text] [Related]  

  • 18. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
    Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
    Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Sentimag system for guiding sentinel node biopsies in patients with breast cancer.
    Abidi H; Bold RJ
    Expert Rev Med Devices; 2024; 21(1-2):1-9. PubMed ID: 37992402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.
    Shiozawa M; Lefor AT; Hozumi Y; Kurihara K; Sata N; Yasuda Y; Kusakabe M
    Breast Cancer; 2013 Jul; 20(3):223-9. PubMed ID: 22240965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.